Metrics as of 10/16/2026, 05:49 PM (Berlin time), refresh in progress.
Quest Diagnostics Stock
Quest Diagnostics Incorporated
Company data
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Country
- United States
- CEO
- James E. Davis
- Employees
- 51,500
- Market cap
- $25.9 B
- IPO
- 17/12/1996
The US company Quest Diagnostics Incorporated is an established service provider in the Healthcare / Medical - Diagnostics & Research sector. Founded in 1967 and headquartered in Secaucus, New Jersey, the company offers a broad spectrum of diagnostic services ranging from routine testing to complex clinical pathology.…
AI-generated company profile based on the figures on this page, last updated on 01/09/2026. Not investment advice.
Quest Diagnostics stock: price history
1D
-1.7%
1W
+1.7%
1M
-4.9%
6M
+20.5%
YTD
+35.4%
1Y
+25.8%
2Y
+57.8%
5Y
+64.9%
10Y
+182.6%
Next earnings date
Next earnings date
22/10/2026 (in 5 days)
Volatility around earnings
~48% stronger price swings than usual
Quest Diagnostics stock scores
- Valuation
Visible after free registration
- Trend
Visible after free registration
- Quality
Visible after free registration
- Dividend
Visible after free registration
- Growth
Visible after free registration
- Insider
Visible after free registration
- Earnings
Visible after free registration
- Revisions
Visible after free registration
- Sentiment
Visible after free registration
- Short Pressure
Visible after free registration
Register for free
Unlock all 11 scores
- 5 credits free on registration
- Access to virtual portfolios and watchlist
- No credit card, no payment details needed
- No subscription, no minimum term
- Our own servers in Germany, no US cloud
Deterministically calculated from financial metrics, not investment advice. Updated nightly, last on 17/10/2026.
Business model & megatrends
Very robust business model with strong megatrend tailwind: wide moat, strong pricing power, predictable revenue.
2 more assignments (Enabler/Second row) Pro-only.
Quest Diagnostics is a leading provider of diagnostic testing services and healthcare information. The company offers a broad range of services spanning from routine examinations to complex clinical pathology tests. Through an extensive network of laboratories, mobile healthcare professionals, and specialized brands, it serves a diverse customer base comprising patients, clinics, hospitals, and insurers. In addition to diagnostic services, Quest Diagnostics also provides information technology solutions for healthcare organizations and delivers risk assessments for the life insurance industry.
- Revenue model
- Transactional
- Recurring revenue
- High
- Pricing power
- Moderate
- Moat
- Wide
- Moat type
- Efficient scale
- Capital intensity
- High
- Customer concentration
- Low
Ask the agents about Quest Diagnostics
Analyst assessment of Quest Diagnostics
PRICE TARGET LOW
US$225.00
CONSENSUS
US$250.00
MEDIAN
US$255.00
PRICE TARGET HIGH
US$260.00
0
STRONG BUY
13
BUY
18
HOLD
3
SELL
0
STRONG SELL
34
TOTAL · Hold
As of: 07/10/2026
Quest Diagnostics stock metrics
P/E
24.63
P/B
3.44
EV/EBITDA
14.24
RETURN ON EQUITY
4.3%
NET MARGIN
10.5%
DEBT/EQUITY
0.85
DIVIDEND YIELD
1.4%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
99.5%
FLOAT SHARES
109,846,079
AVG. DAILY VOLUME (30D)
1,104,192
Insider transactions (SEC)
Davis J. E.
PREVOZNIK MICHAEL E
PREVOZNIK MICHAEL E
PREVOZNIK MICHAEL E
PREVOZNIK MICHAEL E
Attention
1 mention today in US forums, about the same as yesterdayPrice since yesterday: -1.7%
Search (Google Trends)
Forums (Reddit)
Institutional holders
Dividends & Stock splits
Dividends
Stock splits
Smart Money
Register for free
Register now to see which funds are invested
- 5 credits free on registration
- Access to virtual portfolios and watchlist
- No credit card, no payment details needed
- No subscription, no minimum term
- Our own servers in Germany, no US cloud
Comparable stocks
Frequently asked questions about Quest Diagnostics stock
What does Quest Diagnostics do?
Quest Diagnostics Incorporated is a company in the Healthcare sector, Medical - Diagnostics & Research industry, headquartered in United States.
The CEO is James E. Davis, the company employs around 51,500 people.
The IPO was on 17/12/1996; the stock trades on NYSE under the ticker DGX.
What do analysts say about Quest Diagnostics stock?
34 analysts rate the stock, the consensus is Hold (as of 07/10/2026).
The average price target is US$250.00, ranging from US$225.00 to US$260.00, with a median of US$255.00.
This is an external assessment, not a statement by Market Jury.
When does Quest Diagnostics report next?
The next earnings date is 22/10/2026.
Around past earnings, price swings were roughly 48% stronger than usual.
Does Quest Diagnostics pay a dividend?
Yes. The last dividend was US$0.86 per share, ex-date 06/10/2026, paid on 21/10/2026.
The dividend yield is 1.4% (as of 30/06/2026).
Which stocks are comparable to Quest Diagnostics?
Comparable stocks include Thermo Fisher Scientific, Danaher, Natera, Agilent Technologies, IQVIA Holdings, Waters, Illumina and IDEXX Laboratories.
How can I get Quest Diagnostics stock analyzed?
Clicking "Analyze stock" lets five strategies assess Quest Diagnostics against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.